Roundhill GLP-1 & Weight Loss ETF (OZEM) is a Roundhill ETF with a 0.59% expense ratio, 25 holdings and $55MM in net assets. Largest sector: Healthcare (100%).
Fee
0.59%
expense ratio
Net assets
$55MM
Launched
May 21, 2024
Holdings
25
as of Oct 26, 2026
Top 10 weight
68.8%
largest ten holdings
Largest sector
Healthcare
100.0%
Yield
30-day SEC 1.21%
as of Sep 30, 2026
Benchmark
—
OZEM's holdings are as of Oct 26, 2026.
Healthcare
100.0%
1
LLY
ELI LILLY
14.56%
2
NVO
Novo Nordisk A/S
11.91%
3
PFE
PFIZER
8.44%
4
KLRA
Kailera Therapeutics
6.06%
5
1093
CSPC Pharmaceutical Group Ltd
5.65%
6
4519
Chugai Pharmaceutical Ltd
5.29%
7
AMGN
AMGEN
4.74%
8
VKTX
Viking Therapeutics
4.26%
9
AZN
ASTRAZENECA
4.19%
10
ROP
Roche Holding AG
3.68%
11
ZEAL
Zealand Pharma A/S
3.38%
12
128940
Hanmi Pharm Ltd
3.34%
13
1672
Ascletis Pharma
3.09%
14
1276
Jiangsu Hengrui Pharmaceuticals Ltd
2.89%
15
3692
Hansoh Pharmaceutical Group Ltd
2.83%
16
3933
United Laboratories International Holdings Ltd
2.59%
17
1801
Innovent Biologics
2.19%
18
GUBRA
Gubra A/S
2.15%
19
GILD
GILEAD SCIENCES
2.01%
20
MBX
MBX Biosciences
1.80%
21
GPCR
STRUCTURE THERAPEUTICS
1.74%
22
4507
Shionogi & Ltd
1.47%
23
RYTM
Rhythm Pharmaceuticals
1.43%
24
WVE
WAVE LIFE SCIENCES
0.26%
25
CHF
SWISS FRANC
-0.48%
1–25 of 25
Funds listed by how much of their largest holdings they share with OZEM — not a ranking.
Data from Roundhill; prices and returns from market data. Page updated October 29, 2026. Holdings and figures change over time. For information only — not investment advice.